Group 1 - The market regulatory authority has intensified supervision in key livelihood areas such as healthcare, pharmaceuticals, medical devices, food, and children's myopia prevention, announcing ten typical cases of illegal advertising [1][2] - Guangzhou Jianmei Health Technology Co., Ltd. was fined 600,000 yuan for false advertising claims regarding children's eye health products, including "children's lutein" and "eye nose probiotics" [1] - Nala Zun Camel (Guangzhou) Dairy Co., Ltd. was fined 450,000 yuan for misleading claims in its advertising of "camel milk powder" related to disease prevention and treatment [1] - Inner Mongolia Caozhilou Biotechnology Co., Ltd. was fined 200,000 yuan for advertising "organic perilla seed oil" with claims of cancer prevention [1] Group 2 - Chongqing Linhui Tai Business Information Consulting Co., Ltd. was fined 160,000 yuan for advertising "986 germ life enzyme" and other products with false claims about treating serious diseases [2] - Hangzhou Qingbi Brand Management Co., Ltd. was fined 190,000 yuan for misleading claims in advertisements for various health products, including "myopia astigmatism lutein eye patches" [2] - Songyuan Anorectal Hospital was fined 100,000 yuan for false claims regarding its affiliation with reputable medical institutions, affecting public trust and safety [2] Group 3 - Yunnan Yuyao Biopharmaceutical Co., Ltd. was fined 100,000 yuan for violating advertising regulations by promoting a prescription drug, "Sanqi Fatty Liver Pill," inappropriately [3]

Core Viewpoint - The article highlights the increasing regulatory scrutiny on misleading advertisements in key consumer sectors such as healthcare, pharmaceuticals, medical devices, and food, particularly focusing on children's eye care and cancer treatment products. Group 1: Misleading Advertisements - Guangzhou Jianmei Health Technology Co., Ltd. was fined 600,000 yuan for advertising products like "children's lutein" and "eye protection lamp" with false claims about disease prevention and treatment [1] - Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. faced a fine of 450,000 yuan for misleading claims in its "camel milk powder" advertisements regarding health benefits [1] - Jingdezhen Yuxin Yicai Ceramics Co., Ltd. was fined 287,200 yuan for misleading consumers by falsely advertising its ceramic tableware as "Jingdezhen porcelain" [1] Group 2: Health Claims in Food Products - Inner Mongolia Caozhilou Biotechnology Co., Ltd. was fined 200,000 yuan for advertising "organic perilla seed oil" with claims of cancer prevention and treatment [2] - Chongqing Linhui Tai Business Information Consulting Co., Ltd. was fined 160,000 yuan for promoting products like "986 germ life enzyme" with false health claims and misleading language [2] - Hangzhou Qingbi Brand Management Co., Ltd. was fined 190,000 yuan for advertising "nearsightedness and astigmatism eye patches" with exaggerated claims about restoring vision [2] Group 3: Real Estate and Medical Device Misleading Claims - Anhui Kangqiao Real Estate Co., Ltd. was fined 150,000 yuan for misleading advertising regarding unplanned facilities in its real estate promotions [3] - Shandong Chengshi Chengshi E-commerce Co., Ltd. was fined 105,000 yuan for advertising unapproved medical devices and health claims related to digestive issues [3] - Yunnan Yuyao Biopharmaceutical Co., Ltd. was fined 100,000 yuan for violating advertising regulations for prescription drugs [3] Group 4: Regulatory Actions - In 2025, national market regulatory authorities handled 44,521 cases of advertising violations, imposing fines totaling 252 million yuan, reinforcing consumer rights protection [4]

北京商报讯（记者 王寅浩 宋雨盈）1月31日，国家市场监督管理总局公布违法广告典型案例，云南玉药 生物制药有限公司以健康科普的形式发布"三七脂肝丸"处方药广告，违反了"处方药只能在国务院卫生 行政部门和国务院药品监督管理部门共同指定的医学药学专业刊物上作广告"等有关规定。2025年10 月，云南省玉溪市市场监管局依据《中华人民共和国广告法》有关规定，对该公司作出罚款10万元的行 政处罚。 ...

Core Viewpoint - In 2025, the National Market Supervision Administration handled a total of 44,521 advertising violation cases, imposing fines totaling 252 million yuan, effectively strengthening consumer rights protection [1]. Group 1: Advertising Violations - Guangzhou Jianmei Health Technology Co., Ltd. was fined 600,000 yuan for false advertising claims regarding its products, including misleading statements about health benefits and the involvement of international medical experts [1]. - Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. faced a fine of 450,000 yuan for advertising its camel milk powder with false claims related to health improvements and misleading promotional content [2]. - Jingdezhen Yuxin Yicai Ceramics Co., Ltd. was fined 287,200 yuan for misleading consumers by falsely advertising its ceramic products as being from Jingdezhen [3]. - Inner Mongolia Caozhilou Biotechnology Co., Ltd. was fined 200,000 yuan for advertising its organic perilla seed oil with unverified health claims [4]. - Chongqing Linhui Tai Business Information Consulting Co., Ltd. was fined 160,000 yuan for using exaggerated claims in its advertisements for various health products [5]. - Hangzhou Qingbi Brand Management Co., Ltd. was fined 190,000 yuan for advertising products with unsubstantiated health benefits [7]. - Anhui Kangqiao Real Estate Co., Ltd. was fined 150,000 yuan for misleading advertising related to real estate developments [8]. - Shandong Chengshi Chengshi E-commerce Co., Ltd. was fined 105,000 yuan for advertising unapproved medical devices and health products with false claims [9]. - Songyuan Anorectal Hospital was fined 100,000 yuan for misleading advertising regarding its medical services [10]. - Yunnan Yuyao Biological Pharmaceutical Co., Ltd. was fined 100,000 yuan for violating advertising regulations related to prescription drugs [11]. Group 2: Regulatory Actions - In 2025, the National Market Supervision Administration launched a nationwide campaign to rectify advertising market order, focusing on key areas such as healthcare, pharmaceuticals, medical devices, food, and children's vision protection [10]. - The campaign aimed to combat misleading health claims in ordinary food advertisements, illegal live-streaming of advertisements, and false citation content [10]. - A significant number of illegal advertisements related to children's eye protection, cancer treatments, longevity products, and counterfeit medical professionals were targeted during this campaign [10].

Core Viewpoint - In 2025, the State Administration for Market Regulation (SAMR) conducted a nationwide campaign to rectify advertising market order, focusing on key livelihood areas such as healthcare, pharmaceuticals, medical devices, food, and children's myopia prevention, resulting in the investigation of 44,521 advertising violations and fines totaling 252 million yuan [1] Group 1: Advertising Violations - Guangzhou Jianmei Health Technology Co., Ltd. was fined 600,000 yuan for misleading advertisements claiming health benefits related to eye care products [2] - Nala Zun Tuo (Guangzhou) Dairy Co., Ltd. faced a fine of 450,000 yuan for false claims regarding the health benefits of camel milk powder [2] - Jingdezhen Yuxin Yicai Ceramics Co., Ltd. was fined 287,200 yuan for misleading consumers by falsely advertising ceramic tableware as being from Jingdezhen [3] - Inner Mongolia Caozhilou Biotechnology Co., Ltd. was fined 200,000 yuan for advertising organic perilla seed oil with unverified health claims [4] - Chongqing Linhui Tai Business Information Consulting Co., Ltd. was fined 160,000 yuan for promoting various health products with exaggerated claims [5] - Hangzhou Qingbi Brand Management Co., Ltd. was fined 190,000 yuan for advertising eye care patches with unsubstantiated treatment claims [7] - Anhui Kangqiao Real Estate Co., Ltd. was fined 150,000 yuan for misleading real estate advertisements that included unapproved infrastructure claims [8] - Shandong Chengshi Chengshi E-commerce Co., Ltd. was fined 105,000 yuan for advertising unapproved medical devices and health products with false efficacy claims [9] - Songyuan Anorectal Hospital was fined 100,000 yuan for false advertising regarding its medical qualifications [10] - Yunnan Yuyao Biopharmaceutical Co., Ltd. was fined 100,000 yuan for advertising prescription drugs in violation of regulations [10]

Core Insights - The article highlights the increasing prevalence of fatty liver disease in China, with 1 in 3 adults affected, and a concerning trend of younger patients [1] - Fatty liver is often asymptomatic in its early stages, yet it is linked to serious health issues such as hypertension, diabetes, and various cancers [1] - The transition from moderate to severe fatty liver can lead to liver cirrhosis and significantly higher cancer rates compared to healthy individuals [1] Group 1: Health Risks and Statistics - 90% of fatty liver patients show no early symptoms, making it a silent health risk [1] - Moderate fatty liver can progress to cirrhosis in five years, while severe cases have a higher likelihood of developing into liver cancer [1] - Over half of working professionals tend to neglect their health until symptoms become severe, indicating a need for better awareness and proactive health management [1] Group 2: Treatment and Solutions - Traditional views on managing fatty liver emphasize diet and exercise, but recent findings suggest that many cases are not benign and require serious attention [2] - The article introduces Sanqi Fatty Liver Pills, a traditional Chinese medicine approved for treating fatty liver, which aims to address the root causes rather than just the symptoms [2][3] - The product is based on Yunnan's unique natural plant resources and combines traditional medicine with modern pharmaceutical techniques [3] Group 3: Prevention and Management - A comprehensive approach to liver health is recommended, including regular assessments for individuals over 30 and a structured intervention plan involving Sanqi Fatty Liver Pills and physical activity [4] - The article emphasizes the importance of establishing a "prevent-treat-nurture" cycle for liver health, making it as routine as fitness tracking [4] - The narrative stresses that maintaining liver health is crucial for overall well-being, especially for those in demanding work environments [5]